These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Improving the care of individuals with schizophrenia and substance use disorders: consensus recommendations. Ziedonis DM; Smelson D; Rosenthal RN; Batki SL; Green AI; Henry RJ; Montoya I; Parks J; Weiss RD J Psychiatr Pract; 2005 Sep; 11(5):315-39. PubMed ID: 16184072 [TBL] [Abstract][Full Text] [Related]
4. Guidelines for clinical treatment of early course schizophrenia. Keshavan MS; Roberts M; Wittmann D Curr Psychiatry Rep; 2006 Aug; 8(4):329-34. PubMed ID: 16879798 [TBL] [Abstract][Full Text] [Related]
6. Rehabilitation and recovery in schizophrenia. Velligan DI; Gonzalez JM Psychiatr Clin North Am; 2007 Sep; 30(3):535-48. PubMed ID: 17720035 [TBL] [Abstract][Full Text] [Related]
7. Treatment for outpatients with comorbid schizophrenia and substance use disorders: a review. De Witte NA; Crunelle CL; Sabbe B; Moggi F; Dom G Eur Addict Res; 2014; 20(3):105-14. PubMed ID: 24192558 [TBL] [Abstract][Full Text] [Related]
8. Management of substance use disorder in schizophrenia patients: current guidelines. Drake RE CNS Spectr; 2007 Oct; 12(10 Suppl 17):27-32. PubMed ID: 17934387 [TBL] [Abstract][Full Text] [Related]
9. Clinical aspects of substance abuse in persons with schizophrenia. Negrete JC Can J Psychiatry; 2003 Feb; 48(1):14-21. PubMed ID: 12635559 [TBL] [Abstract][Full Text] [Related]
10. Psychosocial treatments for schizophrenia. Mueser KT; Deavers F; Penn DL; Cassisi JE Annu Rev Clin Psychol; 2013; 9():465-97. PubMed ID: 23330939 [TBL] [Abstract][Full Text] [Related]
11. Treatment of adult patients with schizophrenia and complex mental health needs - A national clinical guideline. Baandrup L; Østrup Rasmussen J; Klokker L; Austin S; Bjørnshave T; Fuglsang Bliksted V; Fink-Jensen A; Hedegaard Fohlmann A; Peter Hansen J; Kristine Nielsen M; Sandsten KE; Schultz V; Voss-Knude S; Nordentoft M Nord J Psychiatry; 2016; 70(3):231-40. PubMed ID: 26328910 [TBL] [Abstract][Full Text] [Related]
13. Treatment of substance use disorders in schizophrenia. Bennett ME; Bradshaw KR; Catalano LT Am J Drug Alcohol Abuse; 2017 Jul; 43(4):377-390. PubMed ID: 27715317 [TBL] [Abstract][Full Text] [Related]
14. Pharmacological treatment of schizophrenia and co-occurring substance use disorders. Smelson DA; Dixon L; Craig T; Remolina S; Batki SL; Niv N; Owen R CNS Drugs; 2008; 22(11):903-16. PubMed ID: 18840032 [TBL] [Abstract][Full Text] [Related]
15. Management of schizophrenia with substance use disorders. Lybrand J; Caroff S Psychiatr Clin North Am; 2009 Dec; 32(4):821-33. PubMed ID: 19944886 [TBL] [Abstract][Full Text] [Related]
16. [Drawing up guidelines for the attendance of physical health of patients with severe mental illness]. Saravane D; Feve B; Frances Y; Corruble E; Lancon C; Chanson P; Maison P; Terra JL; Azorin JM; Encephale; 2009 Sep; 35(4):330-9. PubMed ID: 19748369 [TBL] [Abstract][Full Text] [Related]
17. Canadian Schizophrenia Guidelines: Schizophrenia and Other Psychotic Disorders with Coexisting Substance Use Disorders. Crockford D; Addington D Can J Psychiatry; 2017 Sep; 62(9):624-634. PubMed ID: 28886671 [TBL] [Abstract][Full Text] [Related]
18. [Update on current care guidelines: schizophrenia]. Salokangas RK; Tuominen L; Koponen H; Laukkala T; Oksanen J; Pirkola S; Saxen U Duodecim; 2013; 129(8):846-7. PubMed ID: 23720952 [TBL] [Abstract][Full Text] [Related]